Harmony Biosciences CEO Jeffrey Dayno to retire at year-end
Harmony Biosciences said its current CEO, Jeffrey Dayno, will retire from the position at the end of the year.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Dow Jones Newswires reports that Harmony Biosciences’ current Chief Executive Officer Jeffrey Dayno will retire at the end of the year.
The report did not provide details of any other management changes.
why it matters
The leadership transition may matter for assessments of Harmony Biosciences’ future strategic direction and investor focus on the succession process.
instruments
HRMY
sources
- Harmony Biosciences: Current CEO Jeffrey Dayno Will Retire at the End of Year >HRMY — Dow Jones Newswires, 12 October 2026 at 11:01 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗